In our in vitro and in vivo studies, we found that treatment of cells with HF was associated with inactive CDK2 through up-regulation of p21Cip1, while ATS treatment inhibited CDK2 in association with the up-regulation of both p21Cip1 and p27Kip1. The gene discussed is CDKN1A; the disease is hydrops fetalis.